Beta Bionics, Inc. Common Stock BBNX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| I Let | $52.52M+14.5% | $52.06M+11.7% | $50.73M+42.3% | $47.6M+75.3% | $45.87M+155% | |
| Single Use Products | $29.8M+103% | $23.77M+95.0% | $20.72M+159% | $17.3M+256% | $14.66M+475% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Beta Bionics, Inc. Common Stock break its business down?
- Beta Bionics, Inc. Common Stock (BBNX) reports revenue by product across 2 parts — I Let and Single Use Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Beta Bionics, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Beta Bionics, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
